The threshold for diagnosing impaired fasting glucose: a position statement by the European Diabetes Epidemiology Group. (Q30353301)

20 June 2017

title

The threshold for diagnosing impaired fasting glucose: a position statement by the European Diabetes Epidemiology Group. (English)

1 reference

20 June 2017

1 reference

N G Forouhi

1

0 references

Nicholas J. Wareham

10

object named as

N J Wareham

1 reference

20 June 2017

4

J Dekker

1 reference

20 June 2017

8

R Stolk

1 reference

20 June 2017

3

K Borch-Johnsen

1 reference

20 June 2017

B Balkau

2

1 reference

20 June 2017

C Glumer

5

1 reference

20 June 2017

Q Qiao

6

1 reference

20 June 2017

A Spijkerman

7

1 reference

20 June 2017

A Tabac

9

1 reference

20 June 2017

EDEG

11

1 reference

20 June 2017

publication date

9 March 2006

1 reference

20 June 2017

1 reference

20 June 2017

volume

49

1 reference

20 June 2017

issue

5

1 reference

20 June 2017

page(s)

822-827

1 reference

Impaired fasting glucose and cardiovascular outcomes in postmenopausal women with coronary artery disease

20 June 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-006-0189-4

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

21 January 2018

1 reference

12 December 2020

Impaired fasting glucose is not a risk factor for atherosclerosis.

1 reference

12 December 2020

Effects of impaired fasting glucose and impaired glucose tolerance on predicting incident type 2 diabetes in a Chinese population with high post-prandial glucose

1 reference

12 December 2020

Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program

1 reference

12 December 2020

Progression to clinically diagnosed and treated diabetes from impaired glucose tolerance and impaired fasting glycaemia

1 reference

12 December 2020

Blood glucose and risk of cardiovascular disease in the Asia Pacific region

1 reference

12 December 2020

Relative role of major risk factors for Type 2 diabetes development in the historical cohort of the Brisighella Heart Study: an 8-year follow-up.

1 reference

12 December 2020

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

1 reference

12 December 2020

Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius?

1 reference

12 December 2020

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

1 reference

12 December 2020

The Fasting Hyperglycaemia Study: II. Randomized controlled trial of reinforced healthy-living advice in subjects with increased but not diabetic fasting plasma glucose

1 reference

12 December 2020

The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes.

1 reference

12 December 2020

Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia.

1 reference

12 December 2020

Post-challenge hyperglycaemia relates more strongly than fasting hyperglycaemia with carotid intima-media thickness: the RIAD Study. Risk Factors in Impaired Glucose Tolerance for Atherosclerosis and Diabetes.

1 reference

12 December 2020

Changing the definition of impaired fasting glucose: impact on the classification of individuals and risk definition

1 reference

12 December 2020

Fasting proinsulin concentrations predict the development of type 2 diabetes.

1 reference

12 December 2020

Impaired fasting glucose: how low should it go?

1 reference

12 December 2020

Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies.

1 reference

12 December 2020

Lowering the criterion for impaired fasting glucose: impact on disease prevalence and associated risk of diabetes and ischemic heart disease

1 reference

12 December 2020

Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study

1 reference

12 December 2020

Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?

1 reference

12 December 2020

Follow-up report on the diagnosis of diabetes mellitus

1 reference

12 December 2020

Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: results from the Baltimore Longitudinal Study on Aging

1 reference

12 December 2020

Increased mortality risks of pre-diabetes (impaired fasting glucose) in Taiwan

1 reference

12 December 2020

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

12 December 2020

The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature

1 reference

12 December 2020

Lowering the criterion for impaired fasting glucose will not provide clinical benefit

1 reference

12 December 2020

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

12 December 2020

The Fasting Hyperglycaemia Study: III. Randomized controlled trial of sulfonylurea therapy in subjects with increased but not diabetic fasting plasma glucose.

1 reference

12 December 2020

Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study

1 reference

12 December 2020

Normal fasting plasma glucose levels and type 2 diabetes in young men.

1 reference

12 December 2020

10.1007/S00125-006-0189-4

Identifiers

DOI

1 reference

Dimensions Publication ID

20 June 2017

1002098013

0 references

1 reference